Selected research
Industry Growth & Trends
Global Factor XIII Concentrate Industry Growth and Trends Forecast to 2032
Market perspective
The global Factor XIII Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Factor XIII Concentrate include CSL Behring. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Factor XIII Concentrate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Factor XIII Concentrate market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Factor XIII Concentrate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Factor XIII Concentrate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Factor XIII Concentrate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Factor XIII Concentrate Market by Company
CSL Behring
Factor XIII Concentrate Segment by Type
1000IU
1600IU
Factor XIII Concentrate Segment by Application
Hospital
Clinic
Factor XIII Concentrate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor XIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Factor XIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor XIII Concentrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Factor XIII Concentrate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Factor XIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1000IU
- 1600IU
Applications
- Hospital
- Clinic
Companies covered
- CSL Behring
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Factor XIII Concentrate Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Factor XIII Concentrate Sales Estimates and Forecasts (2021-2032)
- 1.3 Factor XIII Concentrate Market by Type
- 1.3.1 1000IU
- 1.3.2 1600IU
- 1.4 Global Factor XIII Concentrate Market Size by Type
- 1.4.1 Global Factor XIII Concentrate Market Size Overview by Type (2021-2032)
- 1.4.2 Global Factor XIII Concentrate Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Factor XIII Concentrate Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Factor XIII Concentrate Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Factor XIII Concentrate Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Factor XIII Concentrate Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Factor XIII Concentrate Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Factor XIII Concentrate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Factor XIII Concentrate Industry Trends
- 2.2 Factor XIII Concentrate Industry Drivers
- 2.3 Factor XIII Concentrate Industry Opportunities and Challenges
- 2.4 Factor XIII Concentrate Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Factor XIII Concentrate Revenue (2021-2026)
- 3.2 Global Top Players by Factor XIII Concentrate Sales (2021-2026)
- 3.3 Global Top Players by Factor XIII Concentrate Price (2021-2026)
- 3.4 Global Factor XIII Concentrate Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Factor XIII Concentrate Major Company Production Sites & Headquarters
- 3.6 Global Factor XIII Concentrate Company, Product Type & Application
- 3.7 Global Factor XIII Concentrate Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Factor XIII Concentrate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Factor XIII Concentrate Players Market Share by Revenue in 2025
- 3.8.3 2025 Factor XIII Concentrate Tier 1, Tier 2, and Tier 3
4 Factor XIII Concentrate Regional Status and Outlook
- 4.1 Global Factor XIII Concentrate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Factor XIII Concentrate Historic Market Size by Region
- 4.2.1 Global Factor XIII Concentrate Sales in Volume by Region (2021-2026)
- 4.2.2 Global Factor XIII Concentrate Sales in Value by Region (2021-2026)
- 4.2.3 Global Factor XIII Concentrate Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Factor XIII Concentrate Forecasted Market Size by Region
- 4.3.1 Global Factor XIII Concentrate Sales in Volume by Region (2027-2032)
- 4.3.2 Global Factor XIII Concentrate Sales in Value by Region (2027-2032)
- 4.3.3 Global Factor XIII Concentrate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Factor XIII Concentrate by Application
- 5.1 Factor XIII Concentrate Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Factor XIII Concentrate Market Size by Application
- 5.2.1 Global Factor XIII Concentrate Market Size Overview by Application (2021-2032)
- 5.2.2 Global Factor XIII Concentrate Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Factor XIII Concentrate Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Factor XIII Concentrate Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Factor XIII Concentrate Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Factor XIII Concentrate Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Factor XIII Concentrate Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Factor XIII Concentrate Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 CSL Behring
- 6.1.1 CSL Behring Company Information
- 6.1.2 CSL Behring Business Overview
- 6.1.3 CSL Behring Factor XIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 CSL Behring Factor XIII Concentrate Product Portfolio
- 6.1.5 CSL Behring Recent Developments
7 North America by Country
- 7.1 North America Factor XIII Concentrate Sales by Country
- 7.1.1 North America Factor XIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Factor XIII Concentrate Sales by Country (2021-2026)
- 7.1.3 North America Factor XIII Concentrate Sales Forecast by Country (2027-2032)
- 7.2 North America Factor XIII Concentrate Market Size by Country
- 7.2.1 North America Factor XIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Factor XIII Concentrate Market Size by Country (2021-2026)
- 7.2.3 North America Factor XIII Concentrate Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Factor XIII Concentrate Sales by Country
- 8.1.1 Europe Factor XIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Factor XIII Concentrate Sales by Country (2021-2026)
- 8.1.3 Europe Factor XIII Concentrate Sales Forecast by Country (2027-2032)
- 8.2 Europe Factor XIII Concentrate Market Size by Country
- 8.2.1 Europe Factor XIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Factor XIII Concentrate Market Size by Country (2021-2026)
- 8.2.3 Europe Factor XIII Concentrate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Factor XIII Concentrate Sales by Country
- 9.1.1 Asia-Pacific Factor XIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Factor XIII Concentrate Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Factor XIII Concentrate Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Factor XIII Concentrate Market Size by Country
- 9.2.1 Asia-Pacific Factor XIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Factor XIII Concentrate Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Factor XIII Concentrate Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Factor XIII Concentrate Sales by Country
- 10.1.1 South America Factor XIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Factor XIII Concentrate Sales by Country (2021-2026)
- 10.1.3 South America Factor XIII Concentrate Sales Forecast by Country (2027-2032)
- 10.2 South America Factor XIII Concentrate Market Size by Country
- 10.2.1 South America Factor XIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Factor XIII Concentrate Market Size by Country (2021-2026)
- 10.2.3 South America Factor XIII Concentrate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Factor XIII Concentrate Sales by Country
- 11.1.1 Middle East and Africa Factor XIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Factor XIII Concentrate Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Factor XIII Concentrate Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Factor XIII Concentrate Market Size by Country
- 11.2.1 Middle East and Africa Factor XIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Factor XIII Concentrate Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Factor XIII Concentrate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Factor XIII Concentrate Value Chain Analysis
- 12.1.1 Factor XIII Concentrate Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Factor XIII Concentrate Production Mode & Process
- 12.2 Factor XIII Concentrate Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Factor XIII Concentrate Distributors
- 12.2.3 Factor XIII Concentrate Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst